News
MOUNJARO prices in the UK could double as the manufacturer will next month hike the rate it charges pharmacies for the fat ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...
AFTER years of fad diets and sweat-soaked gym sessions, ex-Gogglebox favourite Amy Tapper has undergone a major body ...
Drugs such as Ozempic, Wegovy, and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
A new class of drugs has become a phenomenon. GLP-1 receptor agonists, originally developed to treat type 2 diabetes, are now ...
More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...
A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.
Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results